The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.5K Targets. Of those, 1.4M data for 679K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Arylpiperidines as a new class of oxidosqualene cyclase inhibitors.EBI
Ludwig-Maximilians University
Stereoselective synthesis of a new class of potent and selective inhibitors of human¿8,7-sterol isomerase.EBI
Ludwig-Maximilians University
Development of hetero-triaryls as a new chemotype for subtype-selective and potent Sirt5 inhibition.EBI
Ludwig-Maximilians University
Chemical and pharmacological characterization of the TRPML calcium channel blockers ML-SI1 and ML-SI3.EBI
Ludwig-Maximilians University
Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigations.EBI
Ludwig-Maximilians University
Structure-activity relationships of (4-acylpyrrol-2-yl)alkanoic acids as inhibitors of the cytosolic phospholipase A2: variation of the substituents in positions 1, 3, and 5.EBI
Ludwig-Maximilians University
Synthesis, biological evaluation, and structure-activity relationships of 3-acylindole-2-carboxylic acids as inhibitors of the cytosolic phospholipase A2.EBI
Ludwig-Maximilians University